Rogério Gaspar

Rogério Gaspar is a Full Professor of the Faculty of Pharmacy of the University of Lisbon (FFUL).


He also serves as Vice-President of the European Federation for Pharmaceutical Sciences, president of the Portuguese Society of Pharmaceutical Sciences, member of the coordination of the Portuguese Observatory on Health Systems, president of the School Council and Social Pharmacy Department of the Faculty of Pharmacy, University of Lisbon. He also holds positions at the Directorate of the Institute for Bioengineering and Biosciences at Higher Technical Institute, University of Lisbon.


He was Vice-Dean of the University of Lisbon, between 2013 and 2016. Before, he was Sub-Director of School of Arts and Humanities of the University of Lisbon (since September 2012 with the investigation and international relations area responsibility) as well as member of the Scientific Council and Assembly of Faculty. Between 2008 and 2013, he was member of the General Council of University of Lisbon.


He has a degree in Pharmaceutical Science (specialized in Industrial Pharmacy – July 1985), he took a PhD in Pharmaceutical Science (Université Catholique de Louvain, June 1991) and he is affiliated in Pharmacy in University of Coimbra (January 1999). His academics career was developed in University of Coimbra (1985-2006), Catholic University of Louvaina (where he took is PhD. between 1987 and 1991) and Lisbon (since February 2006).


Before he was Coordinator of the Department of Galenic Pharmacy and Pharmaceutical Technology of School of Arts and Humanities of the University of Lisbon (2007-2013), coordinator of the investigation group “Nanomedicine & Drug Delivery Systems” (2007-2013) as well as of the InTraCell_ADD group (Intracellular Trafficking Modulation for Advanced Drug Delivery) at iMed.ULisboa in 2013 e 2014.


His first investigation area is the development of manometric therapeutic systems, where he was managing the projects with the industry pharmaceutical technology area. Nowadays, his investigation is focused on cancer and on modulation of intercellular transport of molecules pharmacologically active areas. He has integrated national and international investigation, including coordination duties. He has performed in consulting of national and international pharmaceutical sector (USA and Europe).


He was also institutional responsible at INFARMED and European Medicines Agency at medicines regulatory area between 1995 and 2002 and between 2008 and 2011. In INFARMED he was: Vice-President of the Medicines Evaluation Division (1996-1999); Vice-President of Executive Board of INFARMED (2000-2002) and member of Executive Board of European Medicines Agency (2000-2002).


He was technical expert in the diplomacy area, in REPER at Brussels, as well as coordinator of the working group of the European Council responsible for the European Clinical Trials Directive (1999-2000). He has participated as coordinator in international actions such as the begging of the process of the mutual recognition EU-Japan in GMPs (2002) areas, establishment of bases for one medicines agency in Cabo Verde, inspector workshop of GMPs at ASEAN (2005-2006), “Look Forward Initiative in Nanomedicine” (European Science Foundation, 2002-2005), ESF Research Conferences in Nanomedicine (Barcelona, 2006, 2008 and 2010), ESF European Summer Schools in Nanomedicine (Cardiff -2007, Lisbon -2009, Halle-Wurtenberg –2011), evaluation and launch of “Centers of Excellence in Nanomedicine” da ANDI - African Network for Drugs and Diagnostics Innovation (United Nations Economic Commission for Africa & African Union, 2011).


Rogério was Executive Committee member of the EUFEPS (European Federation for Pharmaceutical Sciences), where he was Vice-President with the responsibility of “Science Policy” coordination. Although, he was member of some International Scientific Advisory Boards (SABs) such as CIBER-BBN (spanish research network), EuroNanoMedNet-I and II (ERA-NET), TRANS-INT (FP7), NANOFAR (European Doctorate Nanomedicine School). He is also called for doing institucional assessement, of investigation institutes in Portugal, or selection of PhD programs in European Union (Spain, Austria, Norway and South Africa). He is also a member of Editorial/Advisory Board of several scientific international publication, among which stand out: International Journal of Nanomedicine (IF= 3,463/ Dove Medical Press), Nanomedicine: Nanotechnology, Biology and Medicine (IF= 6.930 / Elsevier) e Drug Delivery and Translational Research (Springer, began in 2012).